Stephen F. Mahoney's Net Worth
$2.48 Million
Who is Stephen F. Mahoney?
Stephen F. Mahoney has an estimated net worth of $2.48 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., Magenta Therapeutics, Inc., and Viridian Therapeutics, Inc.\DE.
SEC CIK
Stephen F. Mahoney's CIK is 0001741389
Past Insider Trading and Trends
2018 was Stephen F. Mahoney's most active year for acquiring shares with 4 total transactions. Stephen F. Mahoney's most active month to acquire stocks was the month of April. 2018 was Stephen F. Mahoney's most active year for disposing of shares, totalling 2 transactions. Stephen F. Mahoney's most active month to dispose stocks was the month of April. 2018 saw Stephen F. Mahoney paying a total of $99,995.17 for 169,834 shares, this is the most they've acquired in one year. In 2021 Stephen F. Mahoney cashed out on 5,736 shares for a total of $38,603.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93
President & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
| +8.73% | 6.39K |
—
|
—
| 79.59K |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.03% | 3K |
$0.94 | $2,820.00 | 17.26K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| -28.68% | -5.74K |
$6.73 | -$38,603.28 | 14.26K |
Sep 16
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |